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binoid receptor agonist, CP55940, had similar effects, but 
unlike AEA, also blocked cleavage divisions. CB1 antago-
nists, AEA transport inhibitors, and the cation channel tran-
sient membrane potential receptor V1 (TrpV1) agonist, ara-
chidonoyl vanillic acid (arvanil), as well as arachidonoyl sero-
tonin and dopamine (AA-5-HT, AA-DA) acted as rescue 
substances, partially or totally preventing abnormal embry-
onic phenotypes elicited by AEA or CP55940. Radioligand 
binding of [ 3 H]CP55940 to membrane preparations from 
embryos/larvae failed to show significant binding, consis-
tent with the lack of CB receptor orthologs in the sea urchin 
genome. However, when binding was conducted on whole 
cell lysates, a small amount of [ 3 H]CP55940 binding was ob-
served at the pluteus stage that was displaced by the CB2 
antagonist, SR144528. Since AEA is known to bind with high 
affinity to TrpV1 and to certain G-protein-coupled receptors 
(GPCRs), the ability of arvanil, AA-5-HT and AA-DA to rescue 
embryos from AEA teratogenesis suggests that in sea ur-
chins AEA and other endocannabinoids may utilize both Trp 
and GPCR orthologs. This possibility was explored using bio-
informatic and phylogenetic tools to identify candidate or-
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 Abstract 
 Embryos and larvae of sea urchins ( Lytechinus variegatus, 
Strongylocentrotus droebachiensis ,  Strongylocentrotus purpu-
ratus, Dendraster excentricus),  and starfish ( Pisaster ochraceus ) 
were investigated for the presence of a functional endocan-
nabinoid system. Anandamide (arachidonoyl ethanolamide, 
AEA), was measured in early  L. variegatus embryos by liquid 
chromatography/mass spectrometry. AEA showed a strong 
developmental dynamic, increasing more than 5-fold be-
tween the 8–16 cell and mid-blastula 2 stage. ‘Perturb-and-
rescue’ experiments in different sea urchin species and star-
fish showed that AEA blocked transition of embryos from 
the blastula to the gastrula stage, but had no effect on cleav-
age divisions, even at high doses. The non-selective canna-
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thologs in the  S. purpuratus sea urchin genome. Candidate 
TrpA1 and TrpV1 orthologs were identified. The TrpA1 ortho-
log fell within a monophyletic clade, including both verte-
brate and invertebrate orthologs, whereas the TrpV1 ortho-
logs fell within two distinct TrpV-like invertebrate clades. 
One of the sea urchin TrpV orthologs was more closely re-
lated to the vertebrate epithelial calcium channels (TrpV5-6 
family) than to the vertebrate TrpV1-4 family, as determined 
using profile-hidden Markov model (HMM) searches. Candi-
date dopamine and adrenergic GPCR orthologs were identi-
fied in the sea urchin genome, but no cannabinoid GPCRs 
were found, consistent with earlier studies. Candidate dopa-
mine D 1 , D 2 or   1 -adrenergic receptor orthologs were identi-
fied as potential progenitors to the vertebrate cannabinoid 
receptors using HMM searches, depending on whether the 
multiple sequence alignment of CB receptor sequences con-
sisted only of urochordate and cephalochordate sequences 
or also included vertebrate sequences. 
 Copyright © 2009 S. Karger AG, Basel 
 Introduction 
 Accumulated evidence supports the existence of func-
tional neurotransmitter systems (e.g., acetylcholine, sero-
tonin, dopamine) that regulate key aspects of early (‘pre-
nervous’) embryonic development in vertebrate and in-
vertebrate species, including sea urchins [Buznikov, 1967; 
Gustafson and Toneby, 1970; Gutafson and Toneby, 1971; 
Gustafson et al., 1972; Kirby and Gilmore, 1972; Toneby, 
1974; Lenicque et al., 1977; Palen et al., 1979; Wallace, 
1982; Buznikov, 1990; Buznikov et al., 1996; Colas et al., 
1999a; Colas et al., 1999b; Levin and Mercola, 1999; 
Buznikov et al., 2001a; Buznikov et al., 2005; Levin et al., 
2006]. Sea urchins are the most studied invertebrate mod-
el for investigation of neurotransmitter functions during 
early embryonic stages [Buznikov, 1967; Gustafson and 
Toneby, 1970; Gustafson et al., 1972; Renaud et al., 1983; 
Buznikov, 1990; Buznikov et al., 2001a; Qiao et al., 2003; 
Anitole-Misleh and Brown, 2004; Katow et al., 2004].
 Anandamide (AEA) was the first endogenous agonist 
for cannabinoid receptors to be discovered [Devane et al., 
1992]. It mimics many of the pharmacological properties 
of   9 -tetrahydrocannabinol (THC), the primary psycho-
active substance in Cannabis [Freund et al., 2003]. AEA 
is also an agonist for vanilloid (TrpV1 and ANKTM1) re-
ceptors, and directly inhibits currents generated by L-
type Ca 2+ and TSK-1K + channels [Di Marzo et al., 2001; 
Wang et al., 2006c]. The synthetic AEA analog, R-metha-
nandamide (AM-356) directly blocks acetylcholine-me-
diated responses in  Xenopus oocytes transfected with   7 -
nicotinic receptors (IC 50 approx. 168 n M ), while THC and 
synthetic CB receptor agonists (CP55940 and WIN552122) 
do not affect   7 -nicotinic receptor functions [Oz et al., 
2004]. AEA is released from membrane phospholipid 
precursors,  N -acyl-phosphatidylthanolamines (NAPEs), 
by sequential actions of membrane-bound Ca 2+ -depen-
dent transacylase and phospholipase D (NAPE-PLD) 
when neurons and other cells are stimulated by depolar-
izing agents, neurotransmitters, and hormones [Freund 
et al., 2003; Okamoto et al., 2004]. High levels of NAPE-
PLD are found in brain and testis [Okamoto et al., 2007]. 
Released AEA is quickly taken up from the extracellular 
space by a transporter and hydrolyzed by a membrane-
bound fatty acid amide hydrolase (FAAH), indicative of 
roles in cell signaling [Freund et al., 2003; Maccarrone 
and Finazzi-Agro, 2004]. Retrograde AEA signaling mo-
dulates secretion of neurotransmitters at synapses in cen-
tral and peripheral neurons [Alger, 2002].
 The current study sought to provide evidence for an 
endogenous cannabinoid (endocannabinoid) system in 
embryos of sea urchins and other echinoderms, based on 
results of an earlier drug screen [Buznikov et al., 2002], 
and evidence for a putative CB1-like signaling system in 
sea urchin sperm, which is involved in fertilization and 
prevention of polyspermy [Chang et al., 1993; Schuel et 
al., 1994; Berdyshev, 1999; Schuel and Burkman, 2005]. 
The possibility that fertilized sea urchin eggs and em-
bryos might also synthesize AEA was suggested by the 
presence of NAPE-PLD and FAAH in sea urchin eggs 
[Bisogno et al., 1997]. AEA is synthesized by the uterus 
and appropriate regulation of uterine levels by NAPE-
PLD and FAAH is critical for all stages of prenatal devel-
opment [Fride and Shohami, 2002; Fride, 2008]. Preim-
plantation mouse embryos use their own PLD and FAAH 
to produce an endogenous AEA tone that regulates devel-
opment to the mature blastocyst [Schuel, 2006; Wang et 
al., 2006c; Wang et al., 2008]. During early pregnancy, 
optimally low levels of AEA are required for preparation 
of the blastocyst, its passage through the oviduct, and im-
plantation at appropriate sites [Paria et al., 2002; Wang et 
al., 2006a; Fride, 2008]. Inappropriately high levels of 
AEA disrupt embryonic development by inhibiting cell 
proliferation, promoting apoptosis [Turco et al., 2008] 
and preventing implantation [Wang et al., 2006a]. AEA 
regulates blastocyst development and implantation by ac-
tivating CB1 receptors [Paria et al., 1995; Paria et al., 1998; 
Paria and Dey, 2000; Paria et al., 2002], and plays various 
other roles in pre- and postnatal development [Fride, 
2008; Patinkin et al., 2008] in mammals, as well as in 
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frogs and fish, where it regulates hatching and motility of 
larvae [Migliarini et al., 2006; Migliarini and Carnevali, 
2008; Migliarini and Carnevali, 2009]. Preliminary ex-
periments on sea urchin embryos and larvae had shown 
that cannabinoid/vanilloid receptor ligands, like AEA 
and arachidonoyl ethylene glycol (AA-EG), prevent mal-
formations caused by lipophilic acetylcholine receptor 
agonists [Buznikov et al., 2001b]. Therefore, we reasoned 
that an endogenous cannabinoid system might play a role 
in early echinoderm development, such as regulating 
cleavage divisions, cell differentiation, or morphogenetic 
cell movements during blastulation and gastrulation.
 Materials and Methods 
 Animals 
 The majority of pharmacologic experiments were performed 
on embryos and larvae of sea urchins,  Lytechinus variegatus and 
 Strongylocentrotus droebachiensis . Other echinoderms (sea ur-
chins,  Strongylocentrotus purpuratus and  Dendraster excentricus , 
and starfish,  Pisaster ochraceus ) were also used in some experi-
ments. Proteomic studies were only performed on  L. variegatus 
embryos/larvae. Adult specimens of  L. variegatus  were main-
tained in tanks with filtered, circulating artificial sea water 
(ASW), whereas other echinoderm species used at Friday Harbor 
Laboratories (University of Washington, Wash., USA) were main-
tained in tanks with running natural sea water.
 Pharmacologic ‘Perturb and Rescue’ 
 Fertilization. Adult sea urchins were injected with 0.55  M KCl, 
and gametes harvested. Suspension of mature oocytes of starfish 
were transformed to eggs by treatment with 1   M 1-methylade-
nine. In both cases, eggs were washed with ASW, fertilized, and 
embryos/larvae incubated in multiwell tissue culture plates (100–
150 specimens/well) with drug or vehicle, as described previously 
[Buznikov et al., 2003].
 Pharmacologic Treatment. All experiments were conducted at 
approximately 21 ° C, for  L. variegatus, or at 10 ° C for other echi-
noderm species. Test substances were introduced after fertiliza-
tion, the first cleavage divisions, mid-blastula 2, early or late gas-
trula stages, at a final concentration of 1–100   M . Putative rescue 
substances were given together with corresponding teratogen, or 
10–15 min earlier. Each substance was tested on embryos/larvae 
in multiple experiments ( tables 1 ,  2 ), where embryos (2,000–
3,000) from a single female were used in each experiment. Control 
specimens were incubated in ASW with the same volume of ve-
hicle used to dissolve test chemicals (DMSO, ethanol, methanol 
or deionized/distilled water). Results (changes in cell and/or em-
bryonic/larval phenotype) were documented by brightfield imag-
ing with a Leitz Orthoplan microscope and Spot RT color digital 
Table 1. Teratogenic actions of cannabinoid/vanilloid receptor ligands on development of echinoderm embryos/larvae










type 1 and type 2 cannabinoid 
and vanilloid 
(TrpV1) receptor agonist
10–50 disturbs development from 
the late blastula stage
AM-251, AM-630, ACPA, AA-EGb 











cannabinoid type 1 and type 2 
cannabinoid receptor agonist 
≥ 1–2 disturbs development from 
the first cleavage divisions







WIN55212-2 Sigma cannabinoid type 1 and type 2 
cannabinoid receptor agonist
20–40 disturbs development after 
onset of gastrulation
AM-404, arvanil 1 (2)
AM-630 Tocris type 2 cannabinoid type 2 
receptor antagonist
≥1–2 disturbs development from 
the first cleavage divisions




Capsazepine Tocris vanilloid (TrpV1)
antagonist
≥2.5 disturbs development from 
the first cleavage divisions
not known; VR agonists did not protect 1 (4)
2 (9)
SB366791 Sigma vanilloid (TrpV1)
antagonist
≥1 disturbs development from 
the blastula stage
AM-251, AM-630, AM-404, arvanil, 
AA-5-HTb, AA-DAb, forskolin
2 (11)
AEA (AA-EG). Species: sea urchins: 1 = Lytechinus variegatus; 2 = Strongylocentrotus droebachiensis; 3 = Strongylocentrotus purpuratus; 4 = Den-
draster excentricus; starfish = 5. Pisaster ochraceus; 6 = Evasterias troschelii.
Number of experiments are given in parentheses.
a From commercial sources.
b Synthesized in the laboratory of V.V. Bezuglov (Institute of Bioorganic Chemistry, Moscow, Russia).
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camera (Diagnostic Instruments). Imaging was performed when 
control embryos or larvae were at the mid-blastula, early-late gas-
trula or early prism stage. Malformation phenotypes were scored 
as present when 80–100% of the specimens exhibited a given phe-
notype at a particular drug concentration, which was completely 
absent in vehicle controls.
 Pharmacologic characteristics of drugs used in these experi-
ments, as determined in vertebrates, are listed in  tables 1 and  2 . 
Lipophilic derivatives of particular neurotransmitters [arachi-
donoyl serotonin (AA-5-HT), arachidonoyl dopamine (AA-DA), 
arachidonoyl choline (AA-Ch)] and arachidonoyl vanillic acid 
(arvanil), synthesized by V.V. Bezuglov and collaborators, were 
utilized, as well as 5-HT 2 receptor antagonists, ritanserin (Sigma) 
and cinanserin (Tocris), the cholinergic insecticide, chlorpyrifos 
(ChemService, West Chester, Pa., USA), forskolin, a direct activa-
tor of adenylyl cyclase (Tocris), capsaicin, capsazapine and resin-
feratoxin (Tocris), and arvanil (NIDA drug supply).
 Liquid Chromatography/Mass Spectrometry (LC/MS) of AEA 
 Methods for tissue extraction of AEA were based on those de-
scribed by Cravatt et al. [2001], with modifications. A 2: 1:1 solu-
tion of CHCl 3 /MeOH/50 m M Tris pH 8 (8 ml/0.4 g tissue) was 
prepared for tissue extraction. For targeted LC measurements, 
deuterated AEA (AEA-d 8 ; 0.5 pmol, Cayman Chemicals) was in-
cluded in the solution [Lam et al., 2008]. Embryos/larvae at the 
2-cell, 8–16 cell, and mid-blastula 2 stages were harvested by gen-
tle centrifugation (2,000  g ), placed into CHCl 3 /MeOH/50 m M 
Tris pH 8 solution, and homogenized using dounce tissue grind-
Table 2. Cannabinoid/vanilloid receptor ligands as rescue compounds
Substance Source Pharmacological activity Dose
M 






type 1 and type 2 cannabinoid, 
and vanilloid receptor agonist





VVBb type 1 and type 2 cannabinoid
receptor agonist
















AM-251 Tocris type 1 cannabinoid
receptor antagonist 












10 AA-EGa (AEA), CP55940 1 (3)











40 AA-EGa (AEA), CP55940, 
WIN55212-2, SB366791, AM-630, 
ritanserin, cinanserin, chlorpyrifos, 












VDM-11 Tocris inhibitor of anandamide transport 20–50 AA-EGa (AEA) 1 (3)
Arachidonoyl
tyramine (AA-Tyr)




Footnotes are the same as in table 1.
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ers. Each sample was centrifuged at 2,000  g for 10 min at 4 ° C in 
a glass vial. After centrifugation, the organic and aqueous layers 
were clearly distinguishable with a layer of insoluble material be-
tween them. The organic layer was carefully removed, and con-
centrated under a stream of nitrogen gas. Samples were dissolved 
in 300   l MeOH prior to analysis by LC/MS.
 Detection and quantification of AEA by LC/MS was per-
formed as previously described [Di Marzo et al., 2000], with mod-
ifications. AEA was detected using a C18 reversed phase HPLC 
column (Zorbax C18, 2  ! 50 mm, 1.8   m particle size) operated 
with a linear gradient of 80–100% methanol containing 10 m M 
ammonium acetate over 6 min at a flow rate of 250   l/min, inter-
faced to a TSQ Quantum (Thermo, San Jose, Calif., USA) triple 
quadruple mass analyzer. AEA and AEA-d 8 were detected in se-
lective reaction monitoring mode, monitoring the transitions of 
 m/z 348.4 to 105 and  m/z  356.4 to 108.1 for AEA and AEA-d 8 , re-
spectively. Prior to analysis, the instrument was optimized using 
the compound optimization function of the Xcalibur software.
 Immunocytochemistry  
 Primary Mesenchyme Cells (PMC). Primary antibody, 1D5, 
[Wessel and McClay, 1985] was used to label PMC in normal em-
bryos/larvae and those treated with AEA or AEA + arvanil. Spec-
imens were fixed in cold 2% paraformaldehyde in 60% ASW for 
10 min at room temperature. Following fixation, they were washed 
in cold methanol, placed in small multiwell (Terasaki) plates, 
washed 3  ! 10 min in PBS/2% normal goat serum (PBS-NGS) 
directly in the wells, and incubated with primary antibody 1D5 
(1: 250–1: 500) or no primary antibody (control) overnight at 4 ° C. 
Specimens were washed 3  ! 10 min in PBS-NGS and incubated 
with Cy2-labeled (green) secondary antibody (IgM, 1: 500; Jack-
son Immuno Research Labs) for 1 h in the dark at room tempera-
ture. Following the secondary antibody, specimens were again 
washed in PBS-NGS, and run through an ascending glycerol se-
ries (30, 50, 70% in PBS, for 1 h each), mounted on glass slides, 
coverslipped, and imaged on a Zeiss LSM510 confocal micro-
scope.
 Receptor Binding 
 L. variegatus  sea urchin larvae were collected at the pluteus 
stage by centrifugation (1,600  g , 30 s). The supernatant was dis-
carded, the pellets were weighed, then frozen in a dry ice/isopro-
panol bath and stored at –80 ° C until use. Whole cell lysates were 
prepared by adding 2 mg/ml RIPA cell lysis buffer (Pierce, Rock-
ford, Ill., USA) with 1% Triton and protease inhibitor cocktail
(5   l/mg protein, Chemicon) and homogenized at 4  ° C, then 
placed on an orbital shaker for 2 h at 4 ° C. Lysate was then centri-
fuged in a precooled centrifuge for 20 min at 125,000  g and pro-
tein was measured in the pellet using the Bio-Rad assay. Rat brain 
or spleen P2 membrane fractions were prepared by homogeniza-
tion (10 strokes) in a buffer comprised of 320 m M sucrose, 2 m M 
Tris-EDTA, 5 m M MgCl 2 followed by two rounds of washing and 
centrifugation (5,200  g for 10 min at 4 ° C). The supernatants were 
combined and further centrifuged twice (40,000  g at 4 ° C for 25 
min) and the pellet was resuspended in TME buffer (50 m M Tris-
HCl, pH 7.4, 3 m M MgCl 2 , 1 m M EDTA) for protein determination 
using the Bio-Rad assay.
 Radioligand binding was performed as previously described 
[Devane et al., 1988; Francisco et al., 2002]. The non-selective can-
nabinoid receptor ligand, [ 3 H]CP55940 (specific activity: 0.66 
mCi/ml; 2   M , NIDA Drug Supply), was used to probe sea urchin 
whole cell lysates (100   g protein) or P2 membrane fractions from 
rat brain (25   g) or spleen (50   g). The selective ligands SR141716 
(5   M , NIDA) and SR144528 (1   M , NIDA) were used to define 
binding to CB1 or CB2 receptors, respectively. Whole cell lysates 
or P2 membranes were added to TME assay buffer containing 50 
m M Tris-HCl, pH 7.4, 3 m M MgCl 2 , 1 m M EDTA containing 0.2% 
fatty acid-free BSA. The final assay volume of 500   l was incubat-
ed for 60 min at 30 ° C. The reaction was terminated by rapid filtra-
tion under vacuum ( ! 25 in Hg) using Whatman GF/C filter strips. 
Filters were washed twice with 3-ml aliquots of assay buffer at 0–
4 ° C, dried, dissolved in EcoScintH liquid scintillation cocktail (5 
ml) and counted by liquid scintillation spectroscopy. Between-
group comparisons were made by ANOVA followed by post-hoc 
tests (Tukey or Newman-Keuls) using GraphPad Prism 4.0.
 Bioinformatics 
 Sequence Retrieval and Database Searches. Candidate echino-
derm and ascidian orthologs of vertebrate G-protein-coupled re-
ceptor (GPCR) cannabinoid receptors and the cation channel 
transient membrane potential (Trp) receptors were identified by 
blast sequence similarity searches [Altschul et al., 1997] using
human and mouse orthologs from the UniProt Knowledge-
base (http://www.expasy.org) as query sequences. Queries were 
searched against the echinoderm  S. purpuratus sea urchin ge-
nome, both the GLEAN3 gene (protein) predictions database 
(http://www.hgsc.bcm.tmc.edu/blast.hgsc) and the NCBI sea ur-
chin reference sequences database, and two ascidian genomes, 
 Ciona intestinalis  (sea squirt) and  Ciona savignyi (Pacific sea 
squirt) (www.ensembl.org).  Drosophila melanogaster (fruitfly) 
and  Caenorhabditis elegans (worm) TrpV and TrpA orthologs and 
GPCR receptors of the dopamine-related family from the UniProt 
Knowledgebase (http://www.expasy.org) were also used as query 
sequences to search the ascidian and echinoderm genomes. In ad-
dition, orthologs identified in the echinoderm family were used 
to search the ascidian genome, and vice versa. Echinoderm and 
ascidian homologs were retained for further analysis if they re-
trieved the original query protein as the top hit. The published 
 Branchiostoma floridae CB sequence [Elphick, 2007] was also in-
cluded in some analyses.
 The gene predictions for the sea urchin TrpA1 ortholog from 
the NCBI refseq database, XP_782013.2, and the GLEAN3 gene 
prediction from the Baylor database, GLEAN3 15403, each con-
tained an insertion that was not in the other sequence. Therefore, 
a consensus sequence that was a composite, containing both in-
sertions, was used in this analysis, since both insertions were 
common to TrpA1 proteins from other species. The UniProt, 
NCBI refseq, GLEAN3 or Ensembl IDs for the sequences included 
in these analyses are contained within the protein name in the 
TrpV and GPCR multiple sequence alignments (online suppl. fig. 
S1, S2, www.karger.com/doi/10.1159/000235758). 
 HMMER v2.3.2 (http://hmmer.janelia.org/) was used to com-
plete profile hidden Markov model (HMM) searches of the sea 
urchin genome database. The queries were a series of multiple se-
quence alignments containing different subsets of TrpV and 
GPCR cannabinoid receptor sequences. For the TrpV searches, 
the query alignments contained only sequences from vertebrates, 
whereas the GPCR query alignments contained cannabinoid re-
ceptors from the urochordates  C. intestinalis  and  C. savignyi , and 
the cephalochordate B. floridae alone, or together with vertebrate 
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sequences. The targeted database was the sea urchin GLEAN3 
gene (protein) predictions database (http://www.hgsc.bcm.tmc.
edu/blast.hgsc). The HMM searches were utilized to elucidate an-
cestral relationships that were not statistically significant in 
BLAST pairwise sequence similarity searches or evident in the 
subsequent phylogenetic analysis. HMM searches can be more 
sensitive, because they utilize a statistical encoding of the consen-
sus sequence for the protein family that captures position-spe-
cific conservation information. 
 Molecular Phylogenetic Analysis. ClustalX2 [Larkin et al., 
2007] (http://www.molecularevolution.org/cdc/software/clust-
alx/), T-coffee [Notredame et al., 2000] (http://www.ebi.ac.uk/
Tools/t-coffee/index.html), and MUSCLE [Edgar, 2004] (http://
www.drive5.com/muscle/) were used to perform multiple se-
quence alignments of sea urchin, other invertebrate, and verte-
brate receptor sequences. These sequence alignment programs 
gave similar results for most regions of the proteins. If the
alignment was ambiguous, such as in the case of the N- and C-
terminal regions of the GPCRs, the region was either ignored or 
the alignment generated by T-coffee was used. Bootstrapped 
(1,000 trials) neighbor-joining trees were calculated using Clust-
alX2 v2.0.5, and phylogenetic trees determined by bayesian infer-
ence were calculated using MrBayes v3.1.2 (http://mrbayes.
csit.fsu.edu/). Phylogenetic relationships were mapped with ei-
ther NJplot (http://pbil.univ-lyon1.fr/software/njplot.html) or 
TreeView [Page, 1996] v1.6.6 (http://taxonomy.zoology.gla.ac.
uk/rod/treeview.html).
 Results 
 Developmental Dynamics of AEA Expression in Early 
Sea Urchin Embryos 
 LC/MS was used to quantify AEA in  L. variegatus  sea 
urchin embryos at the 8–16 cell and mid-blastula 2 stages 
( fig. 1 ). The results of these experiments demonstrate the 






















































0 1.0 2.0 3.0 4.0 5.0 6.0
Time (min)
0 1.0 2.0 3.0 4.0 5.0 6.0
Time (min)A B
 Fig. 1. Detection and measurement of AEA by LC/MS in  L. variegatus  embryos. Ion chromatograms of AEA 
and AEA-d 8 in  A 8–16 cell stage and  B mid-blastula 2 stage embryos. AEA was quantified using AEA-d 8 as in-
ternal standard, where 90 pmol was added to the sea urchin samples. The amounts of AEA measured at the 
8–16 cell and mid-blastula stage were 1.33  8 0.12 and 6.8  8 3.5 pmol/g, respectively.  
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reveal a clear developmental dynamic, where the amount 
of AEA at the 8–16 cell stage (  1.33  8 0.12 pmol/g) in-
creases more than 5-fold to reach   6.8  8 3.5 pmol/g by 
the mid-blastula 2 stage. These findings are consistent 
with the presence of NAPE-PLD in sea urchin eggs [Bi-
sogno et al., 1997] and preimplantation mouse embryos 
[Schuel, 2006; Wang et al., 2006c].
 AEA as a Teratogen 
 Results of pharmacologic ‘perturb-and-rescue’ exper-
iments provide evidence for the teratogenic actions of 
AEA in early sea urchin development, and demonstrate 
the ability of a wide spectrum of pharmacologic agents to 
prevent teratogenesis, including AEA transport inhibi-
tors, and antagonists for CB1, CB2 and TrpV1 ( tables 1 ,  2 ; 
 fig. 2–4 ,  7 ). 
A B C
D E F
Control EtOH, 0.03% AEA 5 μM
AEA 10 μM AEA 20 μM AEA 25 μM
*
*
 Fig. 2. Dose-response effects of AEA on  L. 
variegatus sea urchin embryos. AEA was 
introduced at the 2-cell stage (2 h post-fer-
tilization) and larvae imaged at the pluteus 
stage.  A Untreated control;  B vehicle con-
trol;  C AEA 5   M ;  D AEA 10   M ;  E AEA 20 
  M ;  F AEA 25   M . AEA dose-dependent-
ly perturbed development of embryos/lar-
vae compared with controls, preventing 
them from developing the typical mor-
phology of pluteus larvae, with extended 
‘arms’ (arrows). At the highest doses  E ,  F 
cells accumulated in the blastocoel and the 
ectodermal wall was thickened ( F inset, ar-
rowhead). Scale bar = 100   M  A–C ; 50   M 















Control AEA (25 μM) AEA + arvanil (40 μM)
20 μm 20 μm 20 μm
A B C
 Fig. 3. AEA perturbs the movement of PMC shown in green, during gastrulation.  A Vehicle control;  B AEA 25 
  M ;  C vanilloid receptor agonist, arvanil 40   M , partially prevented the effect of AEA, such that the ring of 
PMC at the vegetal pole is clearly visible in both  A and  C (asterisk). Embryos stained with PMC marker 1D5 
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 Critical Period for AEA Teratogenesis. When intro-
duced at the 2-cell stage, AEA at concentrations as high 
as 100   M did not perturb development until after the 
mid-blastula (pregastrulation) stage. However, after this 
time, AEA was teratogenic at much lower concentrations, 
causing malformations to varying degrees, depending on 
dose ( fig. 2 ). At the highest doses, cells accumulated in 
the blastocoel and the ectodermal wall was thickened 
( fig. 2 E, F). Although these cells were originally thought 
to be mesenchymal in origin, immunocytochemistry 
with antibodies to 1D5, a marker of PMC, revealed that 
the number of PMC was unchanged by AEA ( fig. 3 A, B), 
although their migration pattern was clearly perturbed 
( fig. 3 B). This suggests that the cells in the blastocoel are 
not PMC, but cells extruded from the ectodermal wall. 
This view is supported by the observation that, in some 
embryos exposed to high concentrations of AEA, parts of 
the ectodermal wall were destroyed and the cells extrud-
ed into the culture medium. This is consistent with ob-
servations that elevated levels of AEA adversely impact 
the development of preimplantation mouse embryos 
[Schuel, 2006; Wang et al., 2006a].
 Dose-Dependent Protection from AEA Teratogenesis by 
Vanilloid Receptor Ligands. Dose-dependent protection 
from the teratogenic effects of AEA or the VR1/TrpV1 
antagonist SB366791 was seen with several different 
drugs ( table 2 ), including inhibitors of AEA transport 
(AM-404, VDM-11; partial-complete protection), the 
CB1 receptor antagonist, AM-251 ( fig. 5 ), the vanilloid 
receptor (VR1/TrpV1) agonist, arvanil ( fig. 4 ,  5 ), and the 
lipophilic 5-HT derivative, AA-5-HT ( fig. 4 ), all three of 
which exhibited complete protective action.
 Teratogenesis and Rescue by CB2 Receptor Ligands. 
The CB2 receptor antagonist, AM-630, when introduced 
at the 2-cell stage at doses of 5–10   M or greater, blocked 
cleavage divisions followed by death of the embryos 
( fig. 4 B). These effects were partially prevented by AEA, 
and completely prevented by both AA-5-HT and arvanil 
( fig. 4 D–E), as well as AA-DA ( table 2 ). Interestingly, the 
action of these drugs as either rescue substance or terato-
gen was reversed when older embryos (mid-blastula 
stage) were exposed to the same treatments ( fig. 4 G–I). 
Two other non-selective CB receptor agonists, CP55940 
and WIN55212-2, when added at the mid-blastula stage, 
caused an abnormal phenotype similar to AEA, effects 
that were prevented, to varying degrees, by AM-251, ar-
vanil, and the AEA transport inhibitor, AM-404 ( table 2 ). 
The teratogenic effects of WIN55212-2 were blocked by 
A B C D E






+AM-630 40 μM AM-630 40 μM
alone
+AA-5-HT 20 μM +Arvanil 40 μM
 Fig. 4. Developmental dynamics of sensi-
tivity to CB2 receptor antagonist, AM-630 
and AEA. Substances were given at the 2–
4 cell stage ( B–E ) or at mid-blastula 2 ( G–I ). 
Controls ( A ,  F ). AM-630 blocked cleavage 
divisions as shown by embryos composed 
of multiple blastomeres in  B . AEA acted as 
a rescue substance to unblock cleavage di-
visions, as shown in  C . However, when giv-
en at mid-blastula 2, AM-630 partially res-
cued from the effects of AEA ( H ).  A–E Im-
aged at mid-blastula 2;  F–H imaged at late 
gastrula. Scale bar = 50   m. 
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the CB2 antagonist SR144528 ( fig. 6 ). Previous observa-
tions showed that THC did not retard the first cleavage 
division in  S. purpuratus  [Schuel et al., 1987]. Like AEA, 
WIN55212-2 did not affect cleavage divisions when add-
ed at the 2-cell stage. In contrast, CP55940 was a very ac-
tive teratogen, such that concentrations as low as 1–4   M 
caused maximal teratogenic effects from cleavage divi-
sions through the early pluteus stage ( fig. 7 ;  table 2 ), con-
sistent with previous studies on inhibition of the egg jelly-
stimulated acrosome reaction in  S. purpuratus sperm by 
Control
Control
+AA-5-HT 40 μM 











A B C D E F
G H I J K L
 Fig. 5. Action of antagonist of VR1 recep-
tors, SB 366791 and rescue compounds, on 
development of  S. droebachiensis  embryos. 
All substances were given at the mid-blas-
tula 2 stage (17 h, 21 min post-fertiliza-
tion). Specimens were imaged at 26 h, 35 
min ( A–F ) or 42 h 05 min ( G–L ) after fer-
tilization.  A ,  G Control embryos/larvae;
 B ,  H SB366971 1.25   M (abnormal devel-
opment);  C ,  I SB366971 + AA-5-HT 40   M 
(normal development);  D ,  J ;  E ,  K SB366971 
+ arvanil 40   M or AM-251 10   M (good 
protection);  F ,  L SB366971 + forskolin 20 
  M (moderate protection). Temperature 
during experiments 14 ° C. Scale bar = 50 
  m ( A–F ) or 100   m ( G–L ). 
Control (EtOH, 0.03%) SR144 (CB2 antagonist) 2.5 μM
WIN 5 μM WIN + SR144 2.5 μM
A
C D
B Fig. 6. ‘Perturb and rescue’ by type 2 can-
nabinoid receptor ligands. Exposure of 
embryos at the 2-cell stage to a relatively 
low dose of the type 2 cannabinoid ago-
nist, WIN552122, causes a severe malfor-
mation phenotype, where embryos remain 
at the blastula stage with dark (likely dead) 
cells ( * ) in the blastocoel ( C ). This pheno-
type can be completely rescued by the type 
2 cannabinoid antagonist, SR144528 ( D ).
 A Vehicle control (EtOH, 0.03%);  B 
SR144528 (2.5   M );  C WIN (5   M );  D WIN 
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cannabinergic receptor agonists [Schuel and Burkman, 
2005]. Interestingly, the relative teratogenic potency of 
these drugs ( fig. 7 ) followed the same rank order as their 
pharmacologic potency in vertebrates [Breivogel and 
Childers, 2000].
 In the sea urchin  S. droebachiensis , the vanilloid re-
ceptor antagonist, SB366791, at concentrations as low as 
1–2   M , caused abnormal post-blastulation development, 
but did not affect cleavage divisions ( fig. 5 ;  table 2 ). This 
phenotype was similar to that observed in  L. variegatus 
 embryos treated with AEA, effects that could be protect-
ed against by the same rescue substances. However, un-
like AEA-treated embryos, the accumulation of cells in 
the blastocoel, and extrusion into the culture medium 
was not followed by destruction of the ectodermal wall, 
so that abnormal embryos continued to develop, at least 
to the point when controls reached the late gastrula or 
prism stage. When these embryos were partially protect-
ed by rescue substances, the cells in the blastocoel were 
not extruded, but accumulated near the blastopore. An-
other vanilloid receptor antagonist, capsazepine, blocked 
both cleavage divisions and gastrulation. However, no 
rescue substances against capsazepine were identified. 
Even arvanil and resinferatoxin, both very potent vanil-
loid receptor agonists, did not exhibit protective actions 
against capsazepine, suggesting that these effects are not 
mediated by VR/TrpV receptors. Cannabinoid/vanil-
loid-related ligands also protected embryos/larvae against 
some non-cannabinoid teratogens, such as the pesticide 
chlorpyrifos, and several 5-HT 2 receptor antagonists ( ta-
ble 2 ). An especially broad spectrum of protective actions 
was found for arvanil ( table 1 ).
 Receptor Binding  
 Radioligand-binding assays were performed on un-
treated embryos and larvae, using the non-selective CB 
receptor agonist, [ 3 H]CP55940, with or without the selec-
tive CB1 antagonist, SR141716 or the selective CB2 an-
Treatment











2 μM 5 μM
5 μM 10 μM















 Fig. 7. Dose-dependent malformation phenotypes caused by CB receptor agonists. Dose-dependent malforma-
tions caused by different doses of CB receptor agonists, anadamide (AEA), CP55940 (CP), and WIN55212-2 
(WIN) given at the 2-cell stage show order of teratogenicity (CP  1 WIN  1 AEA) that fits their pharmacologic 
potency profiles in vertebrates [Breivogel and Childers, 2000; Prather et al., 2000; Palmer et al., 2002]. 
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tagonist, SR144528. These assays produced no evidence 
of specific binding to CB1, whether they were run on 
membrane preparations or whole cell lysates. However, 
when binding assays were run on whole cell lysates, a 
small amount of [ 3 H]CP55940 binding was seen that 
could be partially displaced by the CB2 receptor antago-
nist, SR144528, but not by the CB1 antagonist, SR141716, 
although the reduction in CP55940 binding by SR144528 
did not reach statistical significance ( table 3 ).
 Bioinformatics 
 TrpV and TrpA Phylogenetic Analyses. TrpV and TrpA1 
echinoderm homologs were identified consistent with 
their presence in nematodes, arthropods, and vertebrates. 
TrpV homologs have 36 ankyrin repeats followed by a cat-
ion channel domain, while TrpA1 homologs have 14–17 
ankyrin repeats in addition to the cation channel. Align-
ments containing both TrpA1 and TrpV excluded   9 of 
the N-terminal ankyrin repeats of TrpA1 and included 
only the 6 ankyrin repeats that were closest to the cation 
channel. Most vertebrate and invertebrate species exam-
ined possessed a single TrpA1 ortholog, but multiple TrpV-
like homologs ( fig. 8 A). The vertebrate and invertebrate 
TrpA1 orthologs formed a monophyletic clade ( fig. 8 Aa) 
that also contained a single sea urchin ortholog. Inverte-
brate TrpV homologs clustered into two main clades – 
OSM-9 from worm and inactive from fruitfly in the first 
clade ( fig. 8 Ab), and the OCR proteins from worm, nan-
chung from fruitfly and nanLIKE from sea squirt in the 
second clade ( fig. 8 Ac). In vertebrates, the TrpV-like ho-
mologs also fell into two families, the epithelial calcium 
channels (TrpV5-6;  fig. 8 Ad), and the vanilloid receptors 
(TrpV1-4;  fig. 8 Ae). Using BLAST searches, we identified 
3 sea urchin TrpV-like homologs that clustered with the 
invertebrate proteins, one with nanchung ( fig. 8 Ac) and 
two with inactive ( fig. 8 Ab). The single  C. intestinalis (sea 
squirt) homolog which we included also clustered with the 
invertebrate nanchung protein ( fig. 8 Ac).
 We tried to elucidate the relationship between the two 
TrpV-like families in invertebrates, nanchung-like and 
inactive-like, and the two families in vertebrates, TrpV5-
like and TrpV1-like, using profile HMM searches (http://
hmmer.janelia.org/), since phylogenetic analyses indicat-
ed that the two vertebrate families were more closely re-
lated to each other than to either of the invertebrate fam-
ilies. HMM searches can be more sensitive tools for data-
base searches, since searching with a statistically encoded 
multiple sequence alignment allows position-sensitive 
conservation information to be utilized in the search. 
The results from the HMM search using only vertebrate 
TrpV5-6-like sequences in the query indicated that the 
nanchung-like GLEAN3 06793 was potentially the sea 
urchin ortholog of this TrpV subfamily. In this search, 
the E-value was statistically significant ( ! 1.0 –3 ) and the 
bit score was both positive and  1 1 15 (log 2 of the number 
of sea urchin sequences in the database), meaning that 
the sequence was a good match for the profile model 
[HMMER User’s Guide, p. 43]. Interestingly, it was also 
the closest sea urchin protein to the vertebrate TrpV1-like 
family, as determined in a second HMM search using 
only vertebrate TrpV1-4 sequences in the query. Compar-
ing the two HMM searches, it is evident that GLEAN3 
06793 was more similar to the profile model of the ver-
tebrate TrpV5-like family than the TrpV1-like fami-
ly. One potential explanation for these results is that 
GLEAN3 06793, and the TrpV1-like and TrpV5-like pro-
teins evolved from a common ancestor, but GLEAN3 
06793 and the TrpV5-like family members share more 
sequence similarity and, presumably, have more function 
in common with the ancestral protein. One implication 
of this evolutionary hypothesis is that the inactive-like 
sea urchin proteins might not have direct descendants 
among the vertebrate TrpV family proteins. A second 
possibility would be that the TrpV1-like family members 
evolved from the ancestor to the inactive-like extant sea 
urchin proteins GLEAN3 21148 and GLEAN3 09599. 
Tissue Total [3H] CP55540 bound







Pluteus 0.00980.002 0.00280.002 0.00780.002 0.00780.005
Brain 0.09980.039 0.04980.022 0.16080.01 0.04880.012*
Spleen 0.04680.002 0.00680.006* ND ND
Experiments were run in duplicate with two replicates for each condition.
* p < 0.05 (one-way ANOVA; Newman-Keuls post-hoc test). ND = Not determined.
Table 3. Binding of non-selective CB 
receptor ligand, [3H]CP55540, in pluteus, 
spleen or brain, 8 CB2 or CB1 receptor 
antagonist
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This hypothesis is supported more by the E-values than 
by the bit scores from the HMM search with TrpV1-like 
proteins as the query.
 Cannabinoid GPCR Phylogenetic Analysis. Consistent 
with published reports of the earliest GPCR cannabinoid 
receptor being identified in the urochordate  C. intestina-
lis [Elphick et al., 2003; Matias et al., 2005] and cephalo-
chordate  B. floridae [Elphick, 2007], and reports of the 
lack of cannabinoid receptors in the sea urchin genome 
[Burke et al., 2006; Sodergren et al., 2006], we did not 
identify any clear echinoderm GPCR cannabinoid recep-
tor orthologs using pairwise sequence similarity search-
es. BLAST searches with human CB1 or CB2 proteins as 
query sequences identified sea urchin proteins with top 
hits on the dopamine D 1 (GLEAN3 22683, GLEAN3 
28351), and related receptors [5-HT 4 (GLEAN3 08947), 
H 2 (GLEAN3 15968),   1 -adrenergic (GLEAN3 14555 and 
GLEAN3 20361)] when blasted back against the human 
genome (data not shown). In addition, different results 
were obtained when blasting the sea urchin genome de-
pending on whether the query was the human CB1 
(GLEAN3 08947, GLEAN3 15968, GLEAN3 14555, 
A B
 Fig. 8. Phylogenetic relationships of Trp and GPCRs in sea ur-
chins, other invertebrates and vertebrates.  A Phylogenetic tree of 
TrpA and TrpV family receptors. Invertebrate and vertebrate spe-
cies contained a single TrpA gene that formed a monophyletic 
clade ( a ). Invertebrate TrpV orthologs fell into 2 families, one that 
contained the worm ( C. elegans ) OSM-9, fruitfly ( D. melanogas-
ter ) inactive ( b ), while the other contained the family of worm 
OCR proteins, fruitfly nanchung, and sea squirt nanLIKE ( c ). 
Vertebrate TrpV orthologs also fell into two families, the epithe-
lial calcium channels (ECaC; TrpV5-6) ( d ) and the TrpV1-like 
channels (TrpV1-4) ( e ). Profile HMM searches against the sea ur-
chin genome, with multiple sequence alignments (MSA) contain-
ing vertebrate TrpV family members as the query, indicated that 
the closest similarity between vertebrate and invertebrate TrpV 
subunits was between the vertebrate epithelial calcium channels 
(ECaC; TrpV5-6) ( d ) and the invertebrate sea urchin ( S. purpura-
tus ) GLEAN3 06793 in the OCR and nanchung clade ( c ). GLEAN3 
09599 was also identified as a homolog to the vertebrate TrpV pro-
teins in the profile HMM searches, with E-values of 1.0 –7 and 1.8 –
3 in the TrpV5-6 and TrpV1-4 searches, respectively. The TrpA1 
ortholog in sea urchins, GLEAN3 15403, had E-values higher 
than 1.5 –4 in the two HMM searches.  B Phylogenetic tree of
GPCRs. Cannabinoid, Edg-like lysophosphatidic acid (LPA) and 
sphingosine 1-phosphate (S1P) receptors were found only in ver-
tebrates and the urochordates sea squirt  (C. intestinalis) and Pa-
cific sea human and fruitfly D 1-5 dopamine receptors formed a 
clade with multiple sea urchin GLEAN3 sequences, including the 
adrenergic-like GLEAN3 21588 and D 1 -like GLEAN3 11320 ( h ). 
HMM searches against the sea urchin genome including all cur-
rently identified GPCR receptors, using the urochordate and 
cephalochordate CB receptors as query, identified the sea urchin 
GLEAN3 21588 as the most similar. HMM searches with verte-
brate CB sequences also included in the search alignment identi-
fied the D 1 -like GLEAN3 11320 as the most similar. All other 
GLEAN3 GPCR receptors in the phylogenetic tree had bit scores 
lower than –55.5 and E-values higher than 3.0 –7 for the first HMM 
search containing only the urochordate and cephalochordate se-
quences. In the search also including vertebrate CB receptors, all 
other GLEAN3 GPCR receptors in the phylogenetic tree had bit 
scores lower than –43.1 and E-values higher than 1.5 –10 . 
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GLEAN3 20361 as top hits) or the human CB2 receptor 
sequence (GLEAN3 28351 as the top hit).
 A phylogenetic analysis of representative cannabi-
noid-related and other GPCRs yielded a tree ( fig. 8 B) with 
three monophyletic clades. One clade contained the ver-
tebrate CB, Edg-like lysophosphatidic acid (LPA) and 
sphingosine 1-phosphate (S1P) receptors, as well as EDG-
like and CB GPCRs from the urochordates  C. intestinalis 
(sea squirt) and  C. savignyi  (Pacific sea squirt) ( fig. 8 Bf). 
No other invertebrate sequences, except for the inverte-
brate chordates, clustered within this group. Human A1, 
A2a, 2b, and A3 adenosine receptors and a single sea ur-
chin adenosine receptor formed a separate monophyletic 
clade ( fig. 8 Bg). In contrast, human D 1-5 and fruitfly do-
pamine receptors formed a clade with multiple sea urchin 
GLEAN3 sequences, including GLEAN3 21588 and 
GLEAN3 11320 ( fig. 8 Bh). 
 We also used HMM searches to query the sea urchin 
genome for GPCR. Given that a single GPCR cannabi-
noid receptor had been identified in  C. intestinalis and  B. 
floridae , a receptor proposed to be the common ancestor 
of both vertebrate CB1 and CB2 receptors [Elphick et al., 
2003; Elphick, 2007], and the fact that the ascidian and 
mammalian CB receptors shared only 29% sequence 
identity suggesting significant functional divergence in 
the cannabinoid receptor after branching of urochor-
dates and cephalocordates from the vertebrate lineage, 
we decided to use the urochordates  C. intestinalis (sea 
squirt) and  C. savignyi (Pacific sea squirt) and cephalo-
chordate  B. floridae CB receptors to query the sea urchin 
genome with the HMM search strategy, since the single 
CB receptor in urochordates and cephalochordates shared 
the nearest ancestry to the pre-gene duplication echino-
derm homolog that gave rise to the vertebrate CB receptor 
and thus was the best candidate to clarify the evolution-
ary origin of the GPCR cannabinoid receptor. Our first 
query MSA consisted of the two urochordate and the 
cephalochordate CB receptor sequences. The top hit in 
this HMM search was the sea urchin GLEAN3 21588, an 
apparent adrenergic ortholog based on NCBI annota-
tions, and the second hit was an H 2 -like sea urchin pro-
tein (GLEAN3 13107), with bit scores of –25.4 and 51.4 
and E-values of 1.6 –8 and 2.0 –7 , respectively. Therefore, 
GLEAN3 21588 is potentially derived from an ancestor 
common to both the urochordate/cephalochordate and 
vertebrate CB receptors. If several vertebrate CB1 and 
CB2 receptors were included with the  Ciona and  Bran-
chiostoma CB sequences in the query MSA, the top 4 hits 
included GLEAN3 21588 and 3 other sea urchin proteins 
from the dopamine/histamine family [GLEAN3 11320 
(D 1 -like), GLEAN3 15968 (H 2 -like) and GLEAN3 28351 
(D 1 -like)] with bit scores ranging from –5.6 to –20.0 and 
E-values ranging from 2.4 –12 to 1.2 –11 . These HMM search 
results against the sea urchin genome using the CB recep-
tors from urochordates, cephalochordates and/or verte-
brates as query suggest that either the sea urchin ( S. pur-
puratus ) GLEAN3 21588, an adrenergic ortholog, or the 
D 1 -like ortholog (GLEAN3 11320) were the most similar 
GPCRs. This result also suggests that these GPCRs are 
potentially derived from an ancestor common to both the 
urochordate/cephalochordate and vertebrate CB recep-
tors. Given the variations in outcome of the profile HMM 
searches, pharmacologic responses will be needed to fur-
ther identify the receptors acting as the source of the en-
docannabinoid response in sea urchin embryos.
 Discussion  
 Developmental Dynamics of AEA in Early 
Echinoderm Embryos 
 AEA was detected in 8–16 cell embryos by LC/MS 
( fig. 1 ), where levels of   1.33 + 0.12 pmol/g were measured. 
By the mid-blastula 2 stage, AEA levels had increased 
more than 5-fold to   6.8 + 3.5 pmol/g. As discussed be-
low, 2-cell (cleavage stage) embryos were insensitive to any 
dose of exogenous AEA. The reasons for this are unclear, 
since 2-cell embryos were not analyzed by LC/MS. It is 
possible that very low levels of AEA are present at this 
early stage, whereas the relevant receptors have not yet 
been expressed. Nevertheless, the current data do show 
detectable levels of AEA as early as the 8–16 cell stage, 
which have increased significantly by the mid-blastula 
stage. Such developmental dynamics may drive critical pe-
riods of sensitivity to the teratogenic effects of AEA and 
the other drugs tested, similar to the deleterious effects of 
inappropriately high levels of AEA on early vertebrate em-
bryos [Wang et al., 2006a; Turco et al., 2008; Wang et al., 
2008]. Indeed, the adverse effects of exogenous AEA, can-
nabinergic receptor agonists, and AEA transport inhibi-
tors suggest the existence of an endogenous AEA tone in 
developing sea urchin embryos similar to the regulatory 
system that operates in early mouse embryos [Schuel, 
2006; Wang et al., 2006a; Wang et al., 2006b], zebrafish 
and frogs [Migliarini et al., 2006; Migliarini and Carne-
vali, 2008, Migliarini and Carnevali, 2009]. Together, 
these findings suggest that AEA-mediated regulation of 
early embryonic development had an ancient origin in the 
evolutionary history of the endocannabinoid system.
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 Stage-Specific Sensitivity to AEA and Receptor 
Ligands 
 Although cleavage stage embryos were insensitive to 
the teratogenic effects of AEA ( table 2 ), AEA clearly pro-
tected embryos from the teratogenic effects of the CB2 
receptor antagonist, AM630 ( fig. 4 ), suggesting that re-
ceptors mediating effects of these ligands allow them to 
exert their typical pharmacologic effects. Sensitivity to 
the teratogenic effects of AEA only emerged after transi-
tion of embryos to the blastula stage, when moderate dos-
es (5–10   M ) caused significant malformations, which 
increased in severity with dose ( fig. 2 ). Higher doses of 
AEA (15–25   M ) disrupted movement of cells along the 
inner ectodermal surface, and disturbed early patterning 
of PMC ( fig. 3 ). However, these doses did not appear to 
decrease the number of PMC, but rather caused accumu-
lation of ectodermal cells in the blastocoel. At the highest 
doses, these cells were sometimes released into the cul-
ture medium, suggesting toxicity.
 There is an obvious inconsistency between the results 
of our ‘perturb-and-rescue’ experiments using CB recep-
tor ligands and failure to detect CB1 and CB2 orthologs in 
the sea urchin genome, despite evidence from radioli-
gand-binding studies in sea urchin sperm suggesting the 
presence of CB receptors similar to those in mammalian 
brain and peripheral organs [Chang et al., 1993], where 
AEA, THC and other CB receptor agonists elicit biologi-
cal responses similar to those observed in mammalian 
neurons and somatic cells [Schuel et al., 1994; Berdyshev, 
2000; Schuel and Burkman, 2005]. However, we believe 
that our in silico evidence, discussed below, provides clues 
to what receptors may be mediating these ‘perturb-and-
rescue’ effects and the observed developmental regulation 
by AEA and other endocannabinoids in sea urchins.
 Involvement of Trp and GPCRs in Developmental 
Endocannabinoid Signaling 
 The partial protective actions of the vanilloid receptor 
(VR1/TrpV1) agonist arvanil against the teratogenic ef-
fects of AEA ( fig. 3 ), together with the ability of cannabi-
noid receptor ligands like AM-251 and AM-630 to pro-
tect against the teratogenic effects of the TrpV1 antago-
nist, SB366971 ( fig. 4 ,  5 ;  table 2 ), suggest that although 
AEA may act via TrpV1 or TrpA1 receptors, as in verte-
brates [Al-Hayani et al., 2001], it may also utilize GPCRs 
to exert its developmental effects. Lipophilic arachodonyl 
5-HT and DA (AA-5-HT, AA-DA) showed good protec-
tive actions against the teratogenic effects of AEA, as well 
as CP55940 (a direct derivative of THC), and SB366971 
( tables 1 ,  2 ). Although these actions are likely mediated 
by VR1/TrpV1 receptors, which mediate actions of these 
drugs in vertebrate brain [Marinelli et al., 2007; de Novel-
lis et al., 2008], they might also exert protective actions 
via ligand-gated ion channels and GPCR-like 5-HT 3A , 5-
HT 1A or D 2 -like receptors, which are known to bind AEA 
in vertebrates [Barann et al., 2002; Centonze et al., 2004; 
Przegalinski et al., 2005; Russo et al., 2005]. Alternatively, 
AA-5-HT and AA-DA might interact with heterodimer-
ic receptors like D 1 /D 2 [So et al., 2007; Faron-Gorecka et 
al., 2008] or mosaic receptors like CB1/D 1 /A2A or CB1/
D 2 /A2A [Fuxe et al., 2008; Marcellino et al., 2008; Na-
varro et al., 2008; Ferré et al., 2009], where the CB com-
ponent is replaced by another GPCR or is not required for 
formation of the mosaic receptor. Although heterodimer/
mosaic receptors have not yet been reported in inverte-
brates, the possibility of their existence is worth consider-
ing. Such a scenario could help explain the finding that, 
even without CB receptors, CB receptor ligands like 
CP55940 (a non-classical cannabinoid), WIN55212-2, 
and AEA exhibit similar dose-dependent teratogenic ac-
tivities in developing sea urchins ( fig. 7 ) as their potency 
profiles in vertebrate tissues would predict [Breivogel and 
Childers, 2000; Prather et al., 2000; Palmer et al., 2002].
 Phylogeny of the Endocannabinoid System 
 The endocannabinoid system in mammals consists of 
a family of lipid-signal molecules that are endogenous li-
gands for cannabinoid receptors, and enzymes respon-
sible for their synthesis and degradation [Mechoulam et 
al., 2006; Sugiura et al., 2006].  N- Archidonoyl ethano-
loamine (AEA, anandamide) was the first endogenous 
ligand for cannabinoid receptors to be discovered [Di 
Marzo et al., 1999]. Currently known endocannabinoids 
also include ethanolamides, sn-2 arachidonyl glycerol (2-
AG), and virodhamine. Since no cannabinoid GPCR or-
thologs have been identified in the sea urchin genome, it 
is possible that cannabinoid receptors evolved after ap-
pearance of the endocannabinoid ligands [McPartland et 
al., 2006; McPartland et al., 2007a], following separation 
of echinoderms from the extant vertebrate lineage. This 
view is consistent with evidence for a primitive cannabi-
noid-like receptor in the urochordate,  C. intestinalis  [El-
phick et al., 2003; Matias et al., 2005] and cephalochor-
date,  B. floridae  [Elphick, 2007]. The need, then, is to 
identify the extant sea urchin receptors that are candi-
dates for a cannabinoid-responsive receptor system in the 
absence of CB receptor orthologs.
 Potential receptors that are present in the sea urchin 
genome that might mediate the developmental effects of 
AEA and other endocannabinoids include a number of 
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ankyrin repeat-containing transient receptor potential 
(Trp) cation channels, annotated as TrpA1 or TrpV1. Both 
bind THC and AEA in vertebrates [Jordt et al., 2004; Kim 
et al., 2007; De Petrocellis et al., 2008], and vertebrate 
TrpA1 has recently been shown to respond to multiple 
phytocannabinoids, including THC [De Petrocellis et al., 
2008]. However, the results of the present study suggest 
that GPCRs may also be involved in endocannabinoid ac-
tions in developing sea urchins. These receptors might be 
in the form of heterodimers or mosaic receptors.
 Based on bioinformatics analyses ( fig. 8 A; online sup-
pl. fig. S1 ), sea urchin Trp receptor homologs exist for 
both the TrpA1 family (vertebrates and invertebrates) 
and TrpV1-6 family (vertebrates), but no CB-like recep-
tors were found, consistent with the lack of cannabinoid 
receptor orthologs in the sea urchin genome [Burke et al., 
2006; Sodergren et al., 2006]. One likely candidate for an 
endocannabinoid-responsive GPCR would be the ances-
tral receptor from which the CB receptor evolved. We 
identified a sea urchin dopamine-like homolog as poten-
tially being the nearest match to this CB receptor, using 
profile HMM searches ( fig. 8 B; online suppl. fig. S2 ). This 
result is interesting for several reasons. First, the verte-
brate D 2 receptor has been reported to bind endocannab-
inoids [Giuffrida et al., 1999; Centonze et al., 2004], rais-
ing the possibility that (1) the sea urchin dopamine recep-
tor homolog may possess an endocannabinoid response 
and (2) endocannabinoid binding may have been a pri-
mordial function of the common GPCR ancestor that 
gave rise to the vertebrate CB receptors. Second, the pres-
ence of CB1-D 2 heterodimers [Navarro et al., 2004; Ferré 
et al., 2008; Marcellino et al., 2008] along with the for-
mation of D 1 -D 2 heterodimers [So et al., 2007; Faron-
Gorecka et al., 2008] have been reported in vertebrate tis-
sues. Third, Beggs et al. [2005] have found D 2 -like recep-
tors in the arthropod  Apis mellifera  (honey bee) that 
overlap in expression with D 1 -like receptors, suggesting 
that this may reflect the presence of D 1 -D 2 receptor com-
plexes in some cells. Given the extent of reported interac-
tions between these GPCRs in organisms ranging from 
arthropods to vertebrates, it is possible that endocanna-
binnoid-dopamine receptor interactions may have been 
a primordial function that was conserved after the gene 
duplication that resulted in the CB receptor.
 In addition, we cannot rule out the use of other non-
canonical receptors by AEA and other cannabinoid re-
ceptor ligands. In this context, it is worth noting evidence 
for cannabinoid receptors in vertebrates in addition to 
CB1 and CB2, such as the orphan receptor GPR55 
[McPartland et al., 2007a; McPartland et al., 2007b], 
which has been identified as a novel cannabinoid recep-
tor with ligand-binding and signaling properties partly 
similar to and partly unique from CB1 and CB2 [Pertwee, 
2007; Ryberg et al., 2007; Lauckner et al., 2008]. Interest-
ingly, AM-251, an analog of the CB1-selective antagonist 
SR141716 [Palmer et al., 2002], is a potent agonist for hu-
man GPR55 [Ryberg et al., 2005; Ryberg et al., 2007] and 
functions as a CB receptor agonist, mimicking the in-
hibitory effects of AEA and THC on fertility of sperm in 
the sea urchin  S. intermedius [Berdyshev, 1999]. BLAST 
searches using human GPR55 (Q9Y2T6) as a query did 
not detect an obvious ortholog in the NCBI  S. purpuratus 
genome, instead hitting on XP_786638, a type 2 soma-
tostatin receptor, originally annotated as CB1-like. Fu-
ture studies will be required to determine whether any of 
the candidate receptors identified here actually function 
as receptors for endocannabinoids or cannabinoid recep-
tor ligands in developing sea urchins and sperm.
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